Interlink Electronics (NASDAQ: LINK) outlined plans to accelerate revenue growth to $50 million in 2026 as the company transitions from a turnaround phase to a high-growth trajectory, according to remarks at the Lytham Partners 2026 Consumer & Technology Investor Summit.
Chief Executive Officer Steven Bronson said the company generated more than $33 million in revenue in its latest fiscal period, up from $12 million in the prior year, and expects to close a pending acquisition within 60 to 90 days that would support its current-year target. The company’s long-term revenue goal remains $100 million, with management emphasizing both organic and acquisition-led growth.
Interlink has completed four acquisitions since 2023, including Conductive Transfers in December 2024 and Calman Technology in March 2023. Bronson highlighted the company’s fully integrated approach, which spans sensor development, firmware, software, and proprietary algorithms, as a key differentiator that supports higher margins and reduces commoditization risk. Gross profit margin stands at approximately 41%.
The company’s product portfolio spans medical applications, environmental monitoring, and smart textiles. In medical robotics, Interlink supplies force sensors for collision and pinch detection in radiation oncology equipment used by Varian Medical Systems and Siemens Healthineers. Its Calman Technology unit produces printed electronics membrane keypads and electrodes for biomedical applications, including RNA and DNA testing platforms and home healthcare devices.
Environmental initiatives include an AI-powered algorithm that synthesizes gas readings into an air quality index, alongside a low-cost wildfire detection sensor platform developed with support from an SBIR grant. The Conductive Transfers unit has also launched a new R&D center focused on commercializing smart textiles and wearables.
Interlink’s stock has delivered a 70% return over the past six months and a 47% gain year-to-date, with CEO Bronson owning approximately 68% of the company’s shares. Analysts project sales growth of 40% for the current year, while the company’s balance sheet shows a current ratio of 4.58 and a debt-to-equity ratio of 0.11.
